The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BACKGROUNDAdults aged ≥65 years who are dually enrolled in Medicare and Medicaid are an at‐risk group in health care. However, to the best of the authors' knowledge, the outcomes of women with gynecologic cancers in this population are unknown.
METHODSThe current study was a population‐based cohort study of North Carolina state cancer registry cases of uterine, ovarian, cervical, and vulvar/vaginal...
BACKGROUNDThe objective of the current study was to evaluate the effect of obesity on pretreatment quality of life (QoL) in gynecologic oncology patients.
METHODSThe authors analyzed collected data from an institution‐wide cohort study of women with gynecologic cancers enrolled from August 2012 to June 2013. The Functional Assessment of Cancer Therapy‐General, site‐specific symptom scales, and the...
Mammalian target of rapamycin (mTOR) inhibitors modulate signaling pathways involved in cell cycle progression, and recent phase II trials demonstrate activity in patients with endometrial cancer. Our objective was to examine the effects of combination therapy with rapamycin and paclitaxel in endometrial cancer cell lines. Paclitaxel inhibited proliferation in a dose‐dependent manner in both cell...
This chapter contains sections titled:
Background
Genes asociated with developing cancer
Genetics underlying gynecologic malignancies
Clinical Scenario 1
Clinical Scenario 2
Clinical Scenario 3
Clinical Scenario 4
Clinical Scenario 5
What do the pathologists at your institution do to avoid missing a “small” cancer?
References
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.